000 01358 a2200397 4500
005 20250515042207.0
264 0 _c20070212
008 200702s 0 0 eng d
022 _a1471-4914
024 7 _a10.1016/j.molmed.2006.09.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzallasi, Arpad
245 0 0 _aTRPV1: a therapeutic target for novel analgesic drugs?
_h[electronic resource]
260 _bTrends in molecular medicine
_cNov 2006
300 _a545-54 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aGene Targeting
_xmethods
650 0 4 _aHumans
650 0 4 _aInflammation
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMigraine Disorders
_xmetabolism
650 0 4 _aModels, Biological
650 0 4 _aNeurons, Afferent
_xmetabolism
650 0 4 _aPain
_xetiology
650 0 4 _aSignal Transduction
650 0 4 _aTRPV Cation Channels
_xantagonists & inhibitors
650 0 4 _aTissue Distribution
650 0 4 _aUrinary Bladder Diseases
_xmetabolism
700 1 _aCruz, Francisco
700 1 _aGeppetti, Pierangelo
773 0 _tTrends in molecular medicine
_gvol. 12
_gno. 11
_gp. 545-54
856 4 0 _uhttps://doi.org/10.1016/j.molmed.2006.09.001
_zAvailable from publisher's website
999 _c16575260
_d16575260